Advances in SCLC Treatment: An Immunotherapeutic Approach

Created using ChatSlide

Join us for an engaging EduWorkshop designed to enhance your understanding of integrating immunotherapy in the management of small-cell lung cancer (SCLC). We'll delve into specific patient cases, examine treatment strategies, and discuss the latest evidence from key trials such as IMpower133 and CASPIAN. Gain insights into the use of durvalumab in LS-SCLC, lurbinectedin in ES-SCLC, and explore relapsed SCLC management, including Tarlatamab for CNS efficacy and clinical trial opportunities....